Literature DB >> 27676347

Sertraline for HIV-associated cryptococcal meningitis - Authors' reply.

Joshua Rhein1, Kirsten Nielsen2, David R Boulware2, David B Meya3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27676347      PMCID： PMC5367916          DOI： 10.1016/S1473-3099(16)30340-1

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

1.  The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections.

Authors:  Bing Zhai; Cheng Wu; Linqi Wang; Matthew S Sachs; Xiaorong Lin
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

2.  Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda.

Authors:  Kyle D Smith; Beatrice Achan; Kathy Huppler Hullsiek; Tami R McDonald; Laura H Okagaki; Ali A Alhadab; Andrew Akampurira; Joshua R Rhein; David B Meya; David R Boulware; Kirsten Nielsen
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

3.  Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints.

Authors:  Ajay Sudan; Joanne Livermore; Susan J Howard; Zaid Al-Nakeeb; Andrew Sharp; Joanne Goodwin; Lea Gregson; Peter A Warn; Tim W Felton; John R Perfect; Thomas S Harrison; William W Hope
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

4.  Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.

Authors:  Joshua Rhein; Bozena M Morawski; Kathy Huppler Hullsiek; Henry W Nabeta; Reuben Kiggundu; Lillian Tugume; Abdu Musubire; Andrew Akampurira; Kyle D Smith; Ali Alhadab; Darlisha A Williams; Mahsa Abassi; Nathan C Bahr; Sruti S Velamakanni; James Fisher; Kirsten Nielsen; David B Meya; David R Boulware
Journal:  Lancet Infect Dis       Date:  2016-03-10       Impact factor: 25.071
  4 in total
  2 in total

1.  Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction Model.

Authors:  Supavit Chesdachai; Radha Rajasingham; Melanie R Nicol; David B Meya; Felix Bongomin; Mahsa Abassi; Caleb Skipper; Richard Kwizera; Joshua Rhein; David R Boulware
Journal:  Open Forum Infect Dis       Date:  2019-10-01       Impact factor: 3.835

Review 2.  Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi.

Authors:  Lucie Peyclit; Hanane Yousfi; Jean-Marc Rolain; Fadi Bittar
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.